Compare PHOS & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHOS | SPOK |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Telecommunications Equipment |
| Sector | Industrials | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.3M | 218.8M |
| IPO Year | 2010 | 2004 |
| Metric | PHOS | SPOK |
|---|---|---|
| Price | $10.84 | $11.64 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 30.2K | ★ 183.3K |
| Earning Date | 11-28-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 10.64% |
| EPS Growth | N/A | ★ 2.74 |
| EPS | N/A | ★ 0.75 |
| Revenue | N/A | ★ $139,708,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.67 |
| Revenue Growth | N/A | ★ 1.49 |
| 52 Week Low | $10.46 | $9.95 |
| 52 Week High | $21.30 | $13.97 |
| Indicator | PHOS | SPOK |
|---|---|---|
| Relative Strength Index (RSI) | 38.03 | 55.99 |
| Support Level | N/A | $10.22 |
| Resistance Level | $13.37 | $12.46 |
| Average True Range (ATR) | 0.98 | 0.41 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 1.34 | 62.27 |
First Phosphate Corp owns and is developing igneous rock phosphate mineral properties in the Saguenay Region of Quebec for the production of phosphoric acid for the production of cathode active material for use in lithium iron phosphate (LPF) batteries for the electric vehicle industry.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.